secwatch.observer — SEC 8-K summary
======================================

Issuer:     United Health Products, Inc. (UEEC)
CIK:        0001096938
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0001477932-23-000656
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Health Products updates FDA PMA progress for HemoStyp Gauze; amends White Lion agreement
--------------------------------------------------------------------------------

- FDA update: batch lot from new mfg shown identical to human trial product; additional lots undergoing consistency testing.
- Company believes consistent production is key criterion for PMA; final application will include test results.
- No assurance that PMA application will be approved by FDA.
- Amended CSPA with White Lion: purchase price set at 90% of VWAP if stock below $0.25 and floor waived (previously 93%).
- Company has raised over $350,000 under the CSPA since September 2022; all other terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1096938/000147793223000656/0001477932-23-000656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1096938/000147793223000656/ueec_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-000656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer